Word: brookes
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Crimson quickly captured the doubles point. Ko and Litvak won an easy 8-4 victory that had Litvak skipping around the court in joy. At the second doubles spot, senior captain Preethi Mukundan and freshman Elizabeth Brook...
...Lonergan said afterwards—and the favorites pulled away from there. The fight in the Hawks stayed for the entire game, personified by Taylor, who had 22 points, six steals and five rebounds the night after his buzzer-beater had given Hartford a 49-47 win over Stony Brook in the first round. He fouled out with 1:37 left and walked off the court in a Hawk uniform for the last time to a standing ovation from the entire crowd and proceeded to hug coach Dan Leibovitz and the rest of his team.“I won?...
...lead in the second. Litvak rallied back to trailing only 5-4 before Zoricic closed out the set. The two played a 15-point tiebreak to decide the third set. Litvak jumped to a 9-3 lead, before closing out the match, 10-5. Freshman Elizabeth Brook played an equally competitive match at No. 4 singles against the Tribe’s Barbara Zidek. Brook lost the first set, 7-5, and the second, 6-2, in a match featuring long and dramatic rallies. “Our freshman were awesome,” Graham said...
...most integral part of the game: putting the ball in the net. And with senior attackman Evan Calvert out for the second straight week with an ankle injury, the Crimson was plagued by a failure to capitalize on scoring opportunities again, as Harvard (0-2) fell to Stony Brook (1-1) by a 13-8 score in front of 1,542 fans at LaValle Stadium in Long Island, N.Y. Despite 50 shots on the afternoon—31 of which were on goal—the Crimson managed just four goals from its starting attackman unit of senior Greg Cohen...
...drug options can only help vaccine makers, giving them a larger well of knowledge upon which they can draw. Yet, even as newer classes of ARVs arrive, drugs cannot be the only answer to AIDS. Already, says Dr. Roy Steigbigel of State University of New York at Stony Brook, and one of the leading investigators of Merck's isentress, volunteers have begun to develop resistance to the integrase inhibitor - a drug that hasn't even yet been approved...